请输入您要查询的百科知识:

 

词条 Directive 75/319/EEC
释义

  1. See also

  2. References

Directive 75/319/EEC of 20 May 1975 on the approximation of the laws of Member States relating to analytical, pharmaco-toxicological and clinical standards and protocols in respect of the testing of proprietary medicinal products. This directive of the European Union sought to bring the benefits of innovative pharmaceuticals to patients across Europe by introducing the mutual recognition, by Member States, of their respective national marketing authorisations.

The Directive states that Member States shall take all appropriate measures to ensure that the documents and particulars for marketing authorization requests are drawn up by experts with the necessary technical or professional qualifications before they are submitted to the competent authorities.

See also

  • EudraLex
  • Directive 75/318/EEC
  • Directive 65/65/EEC1
  • Directive 93/41/EEC
  • Directive 2001/83/EC
  • Regulation of therapeutic goods
  • European Medicines Agency

References

  • Second Council Directive 75/319/EEC of 20 May 1975
{{DEFAULTSORT:Directive 75 319 EEC}}

4 : Pharmaceuticals policy|European Union directives by number|1975 in law|1975 in the European Economic Community

随便看

 

开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。

 

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间:2024/9/29 12:29:43